WallStreetZenWallStreetZen

NASDAQ: ALLO
Allogene Therapeutics Inc Stock Ownership - Who owns Allogene Therapeutics?

Insider buying vs selling

Have Allogene Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Franz B. HumerDirector2024-05-3011,200$2.34
$26.19kSell
Arie BelldegrunDirector2024-05-161,724,137$2.90
$5.00MBuy
Arie BelldegrunDirector2024-05-16344,828$2.90
$1.00MBuy
Geoffrey M. ParkerCHIEF FINANCIAL OFFICER2024-05-16344,828$2.90
$1.00MBuy
David D. ChangPresident and CEO2024-05-16344,828$2.90
$1.00MBuy
Timothy L. MooreChief Technical Officer2024-04-2217,360$3.47
$60.19kSell
David D. ChangPresident and CEO2024-03-1453,393$4.33
$231.19kSell
Geoffrey M. ParkerCHIEF FINANCIAL OFFICER2024-01-30190$3.60
$683.05Buy
Zachary RobertsEVP of RD2024-01-2224,690$3.17
$78.37kSell
Deborah M. MessemerDirector2023-12-1818,640$2.70
$50.31kSell

1 of 2

ALLO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALLO insiders and whales buy or sell their stock.

ALLO Shareholders

What type of owners hold Allogene Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.85%25,363,798$59.60MInstitution
Pfizer Inc12.90%22,032,040$51.78MInsider
Tpg GP A LLC10.95%18,716,306$43.98MInsider
Tpg GP A LLC10.95%18,716,306$43.98MInstitution
Tpg Group Holdings Sbs Advisors Inc10.95%18,716,306$43.98MInsider
Blackrock Inc5.65%9,652,930$22.68MInstitution
State Street Corp5.38%9,184,011$21.58MInstitution
Vanguard Group Inc4.80%8,207,564$19.29MInstitution
David D. Chang3.32%5,666,150$13.32MInsider
Primecap Management Co3.19%5,448,386$12.80MInstitution

1 of 3

ALLO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALLO62.79%37.21%Net BuyingNet Buying
ENGN71.68%27.54%Net BuyingNet Buying
KYTX57.89%42.11%Net BuyingNet Buying
FATE67.68%32.32%Net Selling
PGEN24.42%72.43%Net BuyingNet Selling

Allogene Therapeutics Stock Ownership FAQ

Who owns Allogene Therapeutics?

Allogene Therapeutics (NASDAQ: ALLO) is owned by 76.74% institutional shareholders, 45.48% Allogene Therapeutics insiders, and 0.00% retail investors. Pfizer Inc is the largest individual Allogene Therapeutics shareholder, owning 22.03M shares representing 12.90% of the company. Pfizer Inc's Allogene Therapeutics shares are currently valued at $51.78M.

If you're new to stock investing, here's how to buy Allogene Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.